Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Inv. presentation
Consulting agrmnt
|
|
SYNERGY PHARMACEUTICALS, INC. (SGYP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/12/2019 |
GN
| FINAL DEADLINE: Bronstein, Gewirtz & Grossman, LLC - UXIN, SGYP & MHLD |
| 03/29/2019 |
GN
| Bronstein, Gewirtz & Grossman, LLC Class Action Update - UXIN, SGYP & MHLD |
| 03/21/2019 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – SGYP |
| 03/21/2019 |
GN
| INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Class Action Against Synergy Pharmaceuticals, Inc. (SGYP) and Lead Deadline: April 12, 2019 |
| 03/14/2019 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – SGYP |
| 03/07/2019 |
GN
| Pomerantz Law Firm Announces the Filing of a Class Action on Behalf of Investors in Synergy Pharmaceuticals, Inc. – SGYP |
| 02/28/2019 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Synergy Pharmaceuticals Inc. - SGYP |
| 02/12/2019 |
GN
| SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Synergy Pharmaceuticals Inc. (SGYP) |
| 02/11/2019 |
GN
| SYNERGY PHARMACEUTICALS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that it filed a securities class action lawsuit in the United States District Court for the Eastern District of New York against Synergy Pharmaceuticals, Inc. |
| 08/31/2018 |
GN
| Market Trends Toward New Normal in Sykes Enterprises, Carnival, Covenant Transportation Group, Synergy Pharmaceuticals, Regeneron Pharmaceuticals, and Minerals Technologies — Emerging Consolidated Expectations, Analyst Ratings |
| 07/27/2018 |
GN
| Market Trends Toward New Normal in Egalet, PPG Industries, Synergy Pharmaceuticals, Equity Residential, Array BioPharma, and Holly Energy Partners — Emerging Consolidated Expectations, Analyst Ratings |
| 03/22/2018 |
GN
| Kessler Topaz Meltzer & Check, LLP - Deadline Reminder for Synergy Pharmaceuticals Inc. Shareholders – SGYP |
| 03/20/2018 |
GN
| The Klein Law Firm Reminds Investors of Class Actions on Behalf of Synergy Pharmaceuticals Inc. Shareholders and a Lead Plaintiff Deadline of April 10, 2018 |
| 03/16/2018 |
GN
| SYNERGY PHARMACEUTICALS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Synergy Pharmaceuticals, Inc. |
| 03/15/2018 |
GN
| SGYP EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Actions Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018 |
| 03/14/2018 |
GN
| EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 – SGYP |
| 03/09/2018 |
GN
| SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Synergy Pharmaceuticals Inc. (SGYP) & Lead Plaintiff Deadline: April 10, 2018 |
| 03/03/2018 |
GN
| SYNERGY ALERT: Faruqi & Faruqi, LLP Files Securities Fraud Class Action Complaint Against Synergy Pharmaceuticals, Inc. With Expanded Class Period |
| 03/03/2018 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline – SGYP |
| 02/28/2018 |
GN
| Hagens Berman Reminds Synergy Pharmaceuticals Investors of the April 10, 2018 Lead Plaintiff Deadline in the Securities Class Action Linked to Loan Disclosures |
| 02/27/2018 |
GN
| The Klein Law Firm Announces a Class Action Filed on Behalf of Synergy Pharmaceuticals Inc. Shareholders and a Lead Plaintiff Deadline of April 10, 2018 |
| 02/23/2018 |
GN
| Safirstein Metcalf LLP Announces that a Class Action has been Filed Against Synergy Pharmaceuticals Inc - SGYP |
| 02/23/2018 |
GN
| SGYP SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018 |
| 02/23/2018 |
GN
| IMPORTANT INVESTOR ALERT FOR ALL OWNERS OF SYNERGY PHARMACEUTICALS, INC.: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Synergy Pharmaceuticals, Inc. |
| 02/23/2018 |
GN
| Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Synergy Pharmaceuticals Inc. Shareholders |
| 02/21/2018 |
GN
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Synergy Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 10, 2018 – SGYP |
| 02/21/2018 |
GN
| New Research Coverage Highlights New Senior Investment Group, Simpson Manufacturing, MTGE Investment, Synergy Pharmaceuticals, California Resources, and Gaming and Leisure Properties - Consolidated Revenues, Company Growth, and Expectations for 2018 |
| 02/14/2018 |
GN
| Hagens Berman Alerts Synergy Pharmaceuticals Investors to the Securities Class Action Concerning Loan Disclosures and to the April 10, 2018 Lead Plaintiff Deadline |
| 02/12/2018 |
GN
| SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Synergy Pharmaceuticals Inc. (Nasdaq: SGYP) To Contact Brower Piven Before The Lead Plaintiff Deadline |
| 12/05/2017 |
GN
| Detailed Research: Economic Perspectives on Synergy Pharmaceuticals, California Resources, KKR & Co., New Senior Investment Group, Simpson Manufacturing, and MTGE Investment — What Drives Growth in Today's Competitive Landscape |
| 11/06/2017 |
GN
| Market Trends Toward New Normal in Public Service Enterprise Group, Rigel Pharma, National Oilwell Varco, Ironwood Pharma, Express Scripts, and Synergy Pharma – Emerging Consolidated Expectations, Analyst Ratings |
| 08/23/2012 |
GN
| Synergy Pharmaceuticals Acquires FV-100 Shingles Drug From Bristol-Myers Squibb Company |
| 08/14/2012 |
GN
| Synergy Pharmaceuticals, Inc. Completes Screening and Planned Enrollment in Phase IIb/III Study in Chronic Idiopathic Constipation Patients |
|
|